Fundz
A company that just raised surges hiring in 30 to 60 days. Fundz shows you the money, about a month before the job ad.See it live →

Ascensus Specialties Appoints Dr. Emma Sceats as Chief Executive Officer

PRIVATESep 17, 2026•about 2 hours ago

Position

Chief Executive Officer

Company

Ascensus Specialties

Dr. Emma Sceats
ManufacturingBiotechnology

Description

Ascensus Specialties has appointed Dr. Emma Sceats as their new Chief Executive Officer, effective immediately. She succeeds Paul Burlingame, who will shift to an advisory role.

Company Information

Company

Ascensus Specialties

About

Headquartered in Bellevue, WA, Ascensus Specialties LLC is a global leader in high performance specialty reagents, GMP & custom Synthesis, Catalysts, Ligands, CVD/ALD precursors, Specialty Intermediates, and API (Active Pharmaceutical Ingredient) Synthesis. Ascensus’ chemistries improve the way its clients create their products by making what they do easier, more efficient, safe and more selective. From world-class production sites in Elma, WA; Evans City, PA; Newburyport, MA; and Cambridge, UK, Ascensus has the global reach to ensure that clients can consistently manufacture their products to the highest standards on a global basis.

Don't miss Ascensus Specialties's next move

Get an email the moment Ascensus Specialties changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Ascensus Specialties's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Ascensus Specialties changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.